Hi @ma420
You are showing up everywhere in my portfolio at the moment, good to see you on the NSB board. NSB is a juggernaut in the making, but it doesn't come without risk (management have consistently missed self-imposed deadlines), however, in saying that, 2022 is surely us holders' year. Let me help bring you up to speed, have a read about the company here. Note that the directors interest as this date didn't include the all the current information, so see updated post here on that
Goodluck @ma420 I hope you join us
Ann: NSB partners with leading diffusion MRI company Imeka, page-10
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
